CYTOVAC A/S: Financial statements 2022
CVR: 31262666
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
CYTOVAC A/S (CVR 31262666) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -6,277,000 compared with DKK -13,352,000 the year before. Equity in the 2022 report amounted to DKK -73,260,000. The company had 8 employees in the financial year.
- Revenue
- DKK 0
- Profit/Loss
- DKK -6,277,000
- Equity
- DKK -73,260,000
- Total Assets
- DKK 3,225,000
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | - | -6.3M | -73.3M | 8 |
| 2021 | 960K | - | -13.4M | -67M | - |
| 2020 | 1M | - | -15.7M | -53.6M | - |
| 2019 | - | - | -34.1M | -37.9M | - |
| 2018 | - | - | -30.4M | -3.8M | - |
Official annual report
Keep an eye on CYTOVAC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CYTOVAC A/S has published its annual report for 2021. Revenue came to DKK 960,000, and the net result was DKK -13,352,000.
About CYTOVAC A/S
CYTOVAC A/S was a Danish company of the type Aktieselskab based in København K, founded in 2008. The company has been dissolved on 16 January 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000.
